Peregrine Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-126,613	Closed	-$6.34M	–	341
2021 Q3	$6.34M	Sell	126,613 -24,387	-16%	-$1.48M	0.13%	244
2021 Q2	$9.51M	Sell	151,000 -5,113	-3%	-$328K	0.17%	238
2021 Q1	$14.5M	Sell	156,113 -20,778	-12%	-$2.13M	0.27%	183
2020 Q4	$15.8M	Buy	176,891 +30,266	+21%	+$2.78M	0.3%	140
2020 Q3	$15.2M	Sell	146,625 -73,463	-33%	-$7.92M	0.4%	96
2020 Q2	$17.4M	Sell	220,088 -25,107	-10%	-$1.87M	0.49%	75
2020 Q1	$14.2M	Sell	245,195 -52,850	-18%	-$3.05M	0.51%	72
2019 Q4	$16.1M	Sell	298,045 -3,442	-1%	-$187K	0.41%	113
2019 Q3	$15.8M	Sell	301,487 -22,398	-7%	-$1.04M	0.43%	102
2019 Q2	$15.6M	Buy	323,885 +25,799	+9%	+$1.24M	0.39%	114
2019 Q1	$15.1M	Buy	298,086 +30,346	+11%	+$1.79M	0.38%	121
2018 Q4	$15.9M	Sell	267,740 -42,473	-14%	-$2.74M	0.45%	89
2018 Q3	$20.4M	Sell	310,213 -19,407	-6%	-$1.13M	0.48%	86
2018 Q2	$16.6M	Sell	329,620 -19,348	-6%	-$1.01M	0.42%	110
2018 Q1	$18.4M	Sell	348,968 -17,202	-5%	-$857K	0.45%	90
2017 Q4	$17M	Sell	366,170 -88,687	-19%	-$3.73M	0.4%	101
2017 Q3	$18.4M	Buy	454,857 +131,692	+41%	+$4.76M	0.44%	88
2017 Q2	$11M	Sell	323,165 -912	-0.3%	-$28.2K	0.27%	154
2017 Q1	$9.52M	Buy	324,077 +22,232	+7%	+$677K	0.24%	176
2016 Q4	$9.91M	Buy	+301,845	New	+$9.05M	0.26%	179